Showing results (1091-1100 of 1,133) with videos related to
Sort By:
Pageof 114
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 13, 2020
Case-mix adjustment to compare nationwide hospital performances after resection of colorectal liver metastasesArthur K E Elfrink, Erik W van Zwet, Rutger-Jan Swijnenburg, et al.Journal of Geriatric Oncology|May 22, 2021
Outcomes for systemic therapy in older patients with metastatic melanoma: Results from the Dutch Melanoma Treatment RegistryAnouk Jochems, Esther Bastiaannet, Maureen J B Aarts, et al.European Journal of Cancer (Oxford, England : 1990)|December 29, 2016
Dutch Melanoma Treatment Registry: Quality assurance in the care of patients with metastatic melanoma in the NetherlandsAnouk Jochems, Maartje G Schouwenburg, Brenda Leeneman, et al.Cancers|July 21, 2019
Metastatic Uveal Melanoma: Treatment Strategies and Survival-Results from the Dutch Melanoma Treatment RegistryAnouk Jochems, Monique K van der Kooij, Marta Fiocco, et al.Cancer|November 10, 2024
A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastasesDanielle K DePalo, Michelle M Dugan, Syeda Mahrukh Hussnain Naqvi, et al.European Journal of Cancer (Oxford, England : 1990)|October 5, 2024
Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registryA Özkan, E Kapiteijn, F van den Bos, et al.Annals of Surgical Oncology|October 6, 2022
Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?Stephanie A Blankenstein, Johannes J Bonenkamp, Maureen J B Aarts, et al.Annals of Surgical Oncology|November 7, 2025
Impact of Different Primary Treatment Strategies on Recurrence-Focused Treatment of Pancreatic Ductal AdenocarcinomaPaul C M Andel, Iris W J M van Goor, Thijs J Schouten, et al.Melanoma Research|May 12, 2018
Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomesMaartje G Schouwenburg, Anouk Jochems, Brenda Leeneman, et al.Anti-Cancer Drugs|April 17, 2018
Real-world use, safety, and survival of ipilimumab in metastatic cutaneous melanoma in The NetherlandsAnouk Jochems, Brenda Leeneman, Margreet G Franken, et al.Pageof 114